ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

NUWE Newellis Inc

0.1699
-0.1191 (-41.21%)
27 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Newellis Inc NUWE NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
-0.1191 -41.21% 0.1699 14:00:08
Open Price Low Price High Price Close Price Previous Close
0.1599 0.1461 0.1849 0.1678 0.289
more quote information »

Recent News

Date Time Source Heading
26/4/202423:17GLOBENuwellis Announces Pricing of $2.7 Million Public Offering
09/4/202423:00GLOBENuwellis Announces Launch of Ultrafiltration Therapy Using..
12/3/202408:08EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
08/3/202401:08GLOBELate-Breaking Data Highlighting Benefits of Ultrafiltration..
07/3/202404:02EDGAR2Form 8-K - Current report
06/3/202400:00GLOBENuwellis, Inc. Announces Fourth Quarter and Full Year 2023..
05/3/202422:05IHMARKETNEWSU.S. Futures Dip, Crude Oil Fluctuates
28/2/202401:00GLOBENuwellis, Inc. To Report Fourth Quarter and Full Year 2023..
22/2/202423:58GLOBENuwellis’ Distribution Partner, SeaStar Medical, Receives..
21/2/202409:06GLOBENuwellis, Inc. Reports Inducement Grants Under Nasdaq..
21/2/202400:42GLOBENuwellis to Announce Late-Breaking Clinical Data and Host..
09/2/202409:19EDGAR2Form S-1/A - General form for registration of securities..
07/2/202401:07EDGAR2Form 8-K - Current report
07/2/202401:00GLOBENew Case Series Demonstrates Potential of Aquadex Therapy..
10/1/202409:30EDGAR2Form 8-K/A - Current report: [Amend]
09/1/202401:24EDGAR2Form 8-K - Current report
05/1/202408:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/1/202407:05GLOBENuwellis Receives FDA Clearance for an Additional Dual Lumen..
14/12/202308:05EDGAR2Form 8-K - Current report
29/11/202300:00GLOBENew Real-World Data Highlight the Clinical Benefits of..
15/11/202308:30GLOBENuwellis, Inc. Reports Inducement Grants Under Nasdaq..
08/11/202302:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/11/202300:15EDGAR2Form 8-K - Current report
08/11/202300:00GLOBENuwellis, Inc. Announces Third Quarter 2023 Financial..
02/11/202307:15EDGAR2Form 8-K - Current report
01/11/202323:00GLOBENuwellis Announces Board of Directors Transition
31/10/202323:00GLOBENuwellis’ Strategic Partner, SeaStar Medical, Receives FDA..
19/10/202307:15GLOBENuwellis, Inc. To Announce Third Quarter 2023 Financial..
18/10/202307:30EDGAR2Form 8-K - Current report
18/10/202307:15GLOBENuwellis Announces Closing of $2.25 Million Public Offering..
13/10/202323:30GLOBENuwellis Announces Pricing of $2.25 Million Public Offering..
10/10/202323:30EDGAR2Form 8-K - Current report
10/10/202323:00GLOBENuwellis Provides Regulatory Update on SeaStar Medical’s..
07/10/202307:50EDGAR2Form POS462C - Post-effective amendment to registration..
06/10/202300:27EDGAR2Form AW - Amendment Withdrawal Request
05/10/202308:29EDGAR2Form POS AM - Post-Effective amendments for registration..
02/10/202315:15EDGAR2Form EFFECT - Notice of Effectiveness
29/9/202322:56EDGAR2Form S-1/A - General form for registration of securities..
12/9/202306:15GLOBENuwellis to Present at the Gilmartin Group Emerging Growth..
07/9/202306:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/9/202306:12EDGAR2Form 3 - Initial statement of beneficial ownership of..
19/8/202306:56EDGAR2Form 8-K - Current report
09/8/202302:09EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/8/202322:25EDGAR2Form 8-K - Current report
08/8/202322:15EDGAR2Form 8-K - Current report
08/8/202322:15GLOBENuwellis, Inc. Announces Second Quarter 2023 Financial..
08/8/202322:00GLOBENuwellis Announces Plan for CFO Transition
19/7/202306:15GLOBENuwellis, Inc. To Announce Second Quarter 2023 Financial..
20/6/202322:30GLOBENuwellis Inc. Announces Pilot Agreement With DaVita Inc.
14/6/202306:15GLOBENuwellis to Participate in the Maxim Group Virtual..

Your Recent History

Delayed Upgrade Clock